SPC158
Necítúmúmab
Status:
AfskrifuðApplication date:
30.5.2016Application published:
15.6.2016Grant published:
15.8.2017
Max expiry date:
20.3.2030Medicine name:
PortrazzaMedicine for children:
No
Timeline
Today
30.5.2016Application
15.6.2016Publication
15.8.2017Registration
20.3.2030Expires
Marketing license
IS authorization number:
EU/1/15/1084/001Date:
15.3.2016
Foreign authorization number:
EU/1/15/1084Date:
15.2.2016
Owner
Name:
Imclone LLCAddress:
180 Varick Street, New York US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP1735348